BDBM50010176 CHEMBL107009::[(4S,7R,13R,16S)-16-Acetylamino-4-carbamoyl-13-(3-guanidino-propyl)-6,9,12,15-tetraoxo-1,2-dithia-5,8,11,14-tetraaza-cycloheptadec-7-yl]-acetic acid::[16-Acetylamino-4-carbamoyl-13-(3-guanidino-propyl)-6,9,12,15-tetraoxo-1,2-dithia-5,8,11,14-tetraaza-cycloheptadec-7-yl]-acetic acid
SMILES CC(=O)N[C@@H]1CSSC[C@@H](NC(=O)[C@@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](CCCNC(N)=N)NC1=O)C(N)=O
InChI Key InChIKey=IDMAZMUTHNEQSS-FDYHWXHSSA-N
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 3 hits for monomerid = 50010176
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Affinity DataKi: 780nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Affinity DataKi: 780nMAssay Description:Inhibition of canine platelet-rich plasma agregation induced by ADPMore data for this Ligand-Target Pair
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Affinity DataIC50: 1.62E+4nMAssay Description:Inhibition of canine platelet-rich plasma agregation induced by ADPMore data for this Ligand-Target Pair